Key terms

About DVA

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest DVA news

Yesterday 4:26am ET Barclays Keeps Their Hold Rating on DaVita (DVA) Apr 03 4:01am ET Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX) and DaVita (DVA) Apr 02 10:33am ET DaVita to take hit from CMS final rates for 2025 MA, says Deutsche Bank Mar 05 4:30pm ET DaVita initiated with an Equal Weight at Barclays Mar 05 9:55am ET Early notable gainers among liquid option names on March 5th Mar 05 9:04am ET DaVita expands operations in Brazil and Colombia, enters Chile and Ecuador Feb 26 7:35am ET DaVita price target raised to $136 from $112 at TD Cowen Feb 26 2:22am ET Insider Trading: DaVita (NYSE:DVA) Insider Purchases Shares Worth $5.2M Feb 25 8:55pm ET TD Cowen Sticks to Their Hold Rating for DaVita (DVA) Feb 20 7:57am ET DaVita price target raised to $135 from $130 at Truist Feb 14 10:00am ET DaVita rises 9.5% Feb 14 9:55am ET Early notable gainers among liquid option names on February 14th Feb 14 9:47am ET DaVita rises 11.5% Feb 14 9:08am ET DaVita price target raised to $120 from $90 at Deutsche Bank Feb 14 7:15am ET DaVita price target raised to $130 from $120 at Truist Feb 14 6:55am ET DaVita price target raised to $126 from $115 at BofA Feb 13 4:10pm ET DaVita sees FY24 free cash flow $900M-$1.15B Feb 13 4:10pm ET DaVita sees FY24 adjusted EPS $8.70-$9.80, consensus $8.68 Feb 13 4:09pm ET DaVita reports Q4 adjusted EPS $1.87, consensus $1.59

No recent press releases are available for DVA

DVA Financials

1-year income & revenue

Key terms

DVA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

DVA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms